LMP1 positively regulates the expression of the CSC marker CD44 and several stemness-related genes (Nanog, Oct4, Bmi-1 and SOX2), increases the number of SP cells, enhances the self-renewal properties and promotes the in vivo tumor initiation ability. The gene discussed is PDLIM7; the disease is neoplasm.